1. Introduction {#sec1}
===============

Chronic total occlusion (CTO) of a major epicardial vessel is seen in up to 20% patients undergoing diagnostic angiography and in up to 35% following an episode of acute coronary syndrome.[@bib1], [@bib2], [@bib4] It is one of the most important indication for referral for coronary artery bypass surgery as well.[@bib1], [@bib2], [@bib3], [@bib5] Of late, there are growing data, which indicate that successful treatment of CTOs results in improved symptoms, prolonged life, and improved left ventricular function status.[@bib6], [@bib7], [@bib8], [@bib9], [@bib10] But the attainment of high-end technical skills, sophisticated hardwares, and dedicated training sessions with experts in this field have made a huge impact on the success rates of CTO in developed nations.[@bib10], [@bib11], [@bib12] In developing countries such as India, the situations are different.[@bib11], [@bib13], [@bib14] At one end, the country faces coronary artery disease (CAD) epidemic, and about 20% patients with diagnosed CAD shows the presence of CTO in one of the vessels.[@bib13], [@bib15], [@bib16] At the other end, there is significant lag in attaining required technical skills and availing dedicated CTO hardware. We face many challenges in CTO percutaneous coronary intervention (PCI) especially as the procedure demands huge amount of resources in terms of multiple hardware and technical skill set. As there is no public insurance, all patients end up paying from their own, and poor patients face challenges in approaching private centers for treatment because of high treatment expenses owing to extra requirement of consumables.[@bib17], [@bib18], [@bib19] Public hospitals in India thus receive large influx of patients for CTO PCI. We planned to study the procedural and clinical outcomes of CTO PCI in the public hospital set up in India assessing various clinical objectives such as incidence of procedural complications and major adverse cardiac events (MACEs) such as death, myocardial infarction (MI), and target lesion revascularization (TLR). Improvement in left ventricular function is noted following CTO PCI as many patients exhibit viable and hibernating myocardium supplied by the occluded vessel.[@bib9], [@bib20], [@bib21], [@bib22], [@bib23] We also looked at improvement in left ventricular function status in patient groups who had successful and failed CTO PCI.

2. Methods {#sec2}
==========

2.1. Objectives {#sec2.1}
---------------

We planned to assess the procedural and clinical outcomes in CTO PCI. We looked at angina relief, freedom from TLR, and changes in left ventricular function among success and failure groups.

2.2. Design and settings {#sec2.2}
------------------------

A prospective study of patients undergoing percutaneous coronary angioplasty for totally occluded coronary artery, duration of which is at least 3 months with flow distal to the occlusion, assessed in thrombolysis in myocardial infarction (TIMI) flow grade, is 0 or 1. Any coronary CTO of more than 3 months duration or if duration is unknown but having symptoms suggestive of myocardial ischemia for more than 3 months were subjected to PCI at Department of Cardiology, at a tertiary care public hospital in South India, which caters to a population of approximately 2 million, and it performs on an average 800 PCIs an year. We included all patients with documented or symptomatic ischemia who underwent CTO PCI at the center during the 7-year period from April 2009 to June 2017 with clinical follow-up for improvement of symptoms, left ventricular function, and MACEs such as death, MI, and target vessel revascularization (TVR). The selection of cases for CTO PCI was as per the existing hospital protocol, and patients with left main and triple vessel disease were excluded. The study was conducted after the approval by institutional ethics committee.

2.3. Preprocedural evaluation {#sec2.3}
-----------------------------

Preprocedural evaluation was done to screen for medical comorbidities such as diabetes mellitus, chronic kidney disease, and hematological abnormalities. Left ventricle function status was assessed in terms of ejection fraction (EF) calculated using M-mode measurements or Simpsons method as required in two-dimensional echocardiography. All diabetic individuals were taken care of their blood glucose along with the avoidance of metformin and optimal hydration prior to the procedure, as practised in our department. A detailed angiographic analysis including length of CTO, presence of side branch at proximal cap, calcification at proximal cap, ambiguous proximal cap, and Japanese CTO score were recorded. Japanese CTO score involved a 5-point scoring system as follows: (**1)** blunt stump, (**2)** calcification, (**3)** within lesion bending \>45°, (**4)** occlusion length ≥20 mm, and (**5)** prior failed attempt to revascularize the CTO. Scores of 0 indicate easy, 1 indicative of intermediate, and ≥2 indicates difficult CTO for success. Angiographic characteristics as well as procedural outcomes were compared between success and failure groups.

2.4. Procedure {#sec2.4}
--------------

The procedure of PCI was done under standard protocol with certain variations in technical aspects as clinical and lesion characteristics warrant, which were noted and analyzed in the study. Techniques employed were antegrade guide wire escalation approach, antegrade parallel wire, and dissection/re-entry. The conventional approach was antegrade in this series. The indications for retrograde approach included failed antegrade approach to cross the CTO, which included longer and/or calcified CTO with persistent subintimal wire passage despite parallel wire and intra vascular ultrasound (IVUS)-guided true lumen entry techniques. Primary retrograde approach was chosen in cases with ambiguous proximal CTO and/or aorto-ostial CTO. The retrograde approach included direct wire crossing, kissing wire approach, reverse combined antegrade and retrograde technique (CART), and guide liner reverse CART as specified in the literature. The reverse CART procedures were further defined into classical and contemporary types depending upon the connection zone of antegrade and retrograde systems extending out of the CTO body segment and remaining within the CTO body segment, respectively. The procedural details such as fluoroscopy time, amount of contrast used, guide wires selected, techniques incorporated, restoration of coronary blood flow achieved, assessed in TIMI grades, and the nature of stents employed were studied and analyzed. The success and failure of CTO PCI was documented. Technical success was deﬁned as restoration of TIMI ﬂow grade 2 or 3 at the end of the procedure. Procedural success was deﬁned as technical success without in-hospital cardiac events such as death, MI, urgent coronary artery bypass grafting (CABG), or urgent repeat PCI. The reasons for failure such as failure to cross, failure to track the balloon, and failure to dilate were noted and analyzed. The procedural outcome-related end-points examined in both the success and failed groups included the major complications which were grouped into coronary and non-coronary categories. Coronary complications included dissection, thrombosis, vessel wall hematoma, and perforation. Non-coronary complications involved acute pulmonary edema, heart failure, arrhythmias, and access-related vascular complications.

2.5. Predischarge evaluation {#sec2.5}
----------------------------

All patients were observed in postinterventional care unit. A 12-lead electrocardiography was done for all patients immediately after the procedure and before discharge. Routine renal function assay was done for all patients the day before discharge. Postinterventional therapy included dual antiplatelets and other secondary prevention drugs. Vascular access site care was given for all patients.

2.6. Follow-up {#sec2.6}
--------------

All patients who underwent either successful or failed interventions were followed up for 12 months either on outpatient basis or telephonic conversation every 3 months. Thereafter, the follow-up was every 6 months. Patients in either group were evaluated during their follow-up period for occurrence of clinical outcome--related end-points such as freedom or recurrence of angina, improvement in left ventricular function status, and TVR in the form of CABG or repeat PCI. Echocardiography was performed before and after the procedure and at 6 months intervals to record the changes, if any, in the left ventricular ejection fraction (LVEF) which was calculated using M-mode measurements or Simpson\'s method as required in two-dimensional echocardiography. While routine check angiography was not planned, patients who developed angina were subjected to coronary angiography with an intention to treat.

2.7. Statistical analysis {#sec2.7}
-------------------------

Categorical variables are expressed as numbers and percentages, and continuous variables are expressed as the mean ± standard deviation (SD). After testing for normal distribution, differences were compared using the unpaired Student *t*-test, chi-square test, Mann--Whitney test, and/or analysis of variance (ANOVA) where appropriate. Univariable and multivariable logistic regression analyses were used to identify predictors of procedural success.

A propensity score was constructed using binary logistic regression where the dependent variable was procedural success, and predictors were clinical and angiographic variables \[angiographic variables were adapted from the Japanese chronic total occlusion (J-CTO) score\] that are known to be related to clinical outcomes (MACE): age, gender, diabetes mellitus, arterial hypertension, smoking, previous MI, previous PCI, coronary artery, CTO length, presence of calcifications, tortuosity, and stump morphology. The comparison of continuous variables between the procedural outcomes, clinical outcomes and also between the demographic and clinical factors was carried out by using independent Students t-test/Mann--Whitney *U* test or one-way ANOVA/Kruskal--Wallis test, whichever is appropriate based on the distribution of data and the number of groups. A propensity score-adjusted Cox regression was performed to assess the relation between procedural success and MACE, controlling for group differences.

Event-free survival curves for adverse cardiac events were estimated by Kaplan--Meier method and compared by the log-rank test. A *p* value less than 0.05 was considered as statistically significant. All statistical analyses were performed with SPSS, version 21.

3. Results {#sec3}
==========

**Study population:** The study population consisted of 389 patients with chronic total coronary occlusions in whom percutaneous recanalization was performed.

The characteristics of the patients are summarized in [Table 1](#tbl1){ref-type="table"}. Based on procedural success, the patients were divided into two groups: a procedural successful group (*n* = 339/389, 87.8%) and a procedural failure group (*n* = 50, 12.8%). The mean J-CTO score was 1.78 ± 0.12 (mean ± SD). There were no statistically significant differences in demographic and clinical characteristics between the two groups, except for the higher incidence of a previous MI (*p* = 0.023) and lower incidence of unstable angina (*p* \< 0.001) in the failure group of patients.Table 1Demographics characteristics.Table 1Characteristic \[*n* (%)\]Total number of lesions (*n* = 389)Procedure successful (*n* = 339)Procedure failure (*n* = 50)*p* valueOR (95% CI)Age (years, mean ± SD)58.5 ± 9.558.3 ± 9.658.8 ± 9.30.69--Male318 (81%)297 (88%)40 (80%)0.450.888 (0.423--1.471)Family history of CAD89 (22%)47 (14%)42 (84%)0.471.291 (0.733--1.937)Diabetes101 (25.9%)91 (27%)10 (20%)0.191.347 (0.826--2.642)Insulin dependent14 (3.5%)11 (4%)3 (6%)0.650.676 (0.262--2.303)Hypertension313 (80.4%)274 (81%)39 (79%)0.701.233 (0.616--2.046)Hypercholesterolemia313 (78%)273 (80.8%)40 (79.2%)0.141.450 (0.870--2.728)Smoking status Never159 (41%)138 (40.7%)21 (42%)0.991.003 (0.614--1.637) Smoker121 (31.1%)108 (32%)13 (26%)0.301.226 (0.773--2.276) Ex-smoker110 (28.2%)94 (28%)16 (33%)0.300.660 (0.451--1.281)Previous MI236 (60.6%)200 (59%)36 (72%)0.02[a](#tbl1fna){ref-type="table-fn"}0.449 (0.326--0.925)LVEF (%)45 ± 1346 ± 1444 ± 120.188--LVEF \< 40%129 (33%)111 (31%)18 (37%)0.2810.857 (0.455--1.257)Previous CABG41 (11%)36 (12%)5 (10%)0.551.371 (0.574--2.814)Previous PCI Number260 (67%)223 (66%)33 (67%)0.820.842 (0.564--1.574) Same artery41 (11%)36 (12%)5 (10%)0.731.243 (0.528--2.476) Other artery91 (23.3%)69 (22%)21 (22%)0.991.1 (0.558--1.792) Stable angina pectoris151 (38.8%)121 (58%)30 (61%)0.680.8 (0.550--1.473) Unstable angina pectoris98 (24.8%)92 (27%)6 (12%)\<0.01[a](#tbl1fna){ref-type="table-fn"}3.508 (1.689--7.285)Number of diseased vessels 1178 (46%)155 (46%)23 (48%)0.730.919 (0.566--1.490) 2136 (35%)122 (58%)16 (33%)0.721.096 (0.659--1.823) 373 (19%)62 (19%)11 (22%)0.991.003 (0.543--1.854)Concomitant therapy Beta-blocker241 (62%)210 (62%)31 (63%)0.8591.046 (0.636--1.722)ACE inhibitor and/or ARB313 (81%)271 (80%)42 (84%)0.4011.312 (0.695--2.477) Statin331 (85%)291 (86%)40 (81%)0.2660.694 (0.364--1.324) Nitrate102 (26%)74 (22%)28 (27%)0.3631.296 (0.741--2.268) DAPT389 (100%)339 (100%)50 (100%)----[^1][^2]

**Angiographic characteristics(**[Table 2](#tbl2){ref-type="table"}**):** Regarding angiographic characteristics, there were certain differences between the successful and failure groups---lesions longer than 20 mm, more tortuous vessels, and calcifications were all more frequent in the failure group. Procedural success was achieved in 339 lesions (87.8%). Based on these procedural outcomes, the lesions were divided into two groups: a procedural success group (*n* = 339) and failure group (*n* = 50). There were no statistically significant differences in procedural characteristics between the two groups. The mean J-CTO score in successful and failed groups were not different. However on analyzing different components of the score, longer CTO length (≥20 mm), severe calcification, blunt proximal cap, and tortuosity were more prevalent in the failed group. The periprocedural complication rate was similar in both groups ([Table 3](#tbl3){ref-type="table"}).Table 2Angiographic and procedural characteristics.Table 2Angiographic characteristicNo of CTO (*n* = 389)Procedure successful (*n* = 339)Procedure failure (*n* = 50)*p* valueCTO artery \[*n* (%)\] RCA177 (45.5)152 (45)25 (51)0.390 LAD113 (29)101 (30)12 (25)0.393 Cx92 (24)81 (24)11 (24)0.909Localization of CTO \[*n* (%)\] Ostial36 (9)33 (10)3 (6)0.139 Proximal116 (29.1)99 (31)17 (35)0.609 Middle171 (44)149 (44)22 (44)0.180 Distal58 (15)49 (14.5)9 (16)0.890 In-stent CTO \[*n* (%)\]21 (5.5)18 (5.3)3 (6)0.107 Duration of occlusion (months, mean ± SD)36.6 ± 50.034.4 ± 44.639.8 ± 56.90.507 Diameter of CTO vessel (mm, mean ± SD)3.0 ± 0.43.1 ± 0.43.0 ± 0.40.273 J-CTO score mean ± SD1.78 ± 0.121.72 ± 0.172.0 ± 0.210.823CTO length \[*n* (%)\] ≤10 mm86 (22)65 (19)21 (42)0.281 10--20 mm107 (25)92 (27)15 (30)0.035 ≥20 mm186 (58)156 (46.2)30 (60)0.003 Tortuosity \[*n* (%)\]159 (41)119 (35.1)40 (80)0.000Calcification \[*n* (%)\] Mild321 (82.5)293 (75.3)28 (56)0.011 Moderate25 (6.4)16 (4.7)9 (18)0.015 Severe43 (11)6 (1.7)37 (74)0.000Stump morphology (*n* (%)) Blunt117 (29.4)100 (29.4)17 (54)0.000 Tapered272 (69.9)252 (74)20 (40)0.000 Side branch (*n* (%))172 (44)151 (44.5)21 (44)0.003 In-stent CTO (*n* (%))21 (5)18 (5.3)3 (6)0.107Technical approach-Antegrade351 (90.2)304 (89.6)47 (94)0.057-Retrograde38 (9.8)35 (10.1)3 (6)0.057Number of wires per lesion2.5 ± 0.92.54 ± 0.82.43 ± 0.80.447Fluoroscopic time (minutes)27.8 ± 22.329.3 ± 24.124.9 ± 18.20.090Contrast volume (mL)326 ± 176.9346.2 ± 170.8291.4 ± 183.50.008[^3]Table 3CTO techniques used among successful cases (*n* = 339).Table 3Technique*n* (%)Antegrade wire escalation216 (63.71)Parallel wire technique90 (26.54)Antegrade dissection and re entry18 (5.32)IVUS-guided proximal cap penetration5 (1.43)Retrograde wire direct crossing3 (0.88)Retrograde wire kissing technique5 (1.43)Reverse CART (classical)19 (5.60)Reverse CART (contemporary)6 (1.96)Retrograde rendezvous2 (0.58)Guide liner reverse CART3 (0.88)[^4]

The CTO techniques included antegrade approach in 351 patients (90.2%) \[successful in 304 patients (89.6%) patients\] ([Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}). The different antegrade and retrograde techniques that were involved are detailed in [Table 3](#tbl3){ref-type="table"}. No statistically significant association was seen between the occluded vessel targeted for intervention and the procedural success (*p* = 0.13 by chi-square test). The distribution of de novo occlusion and in-stent re-occlusion did not affect the procedural outcome (*p* = 1.0 by Fishers exact test) as well. Miracle series (37%) and Gaia series (35%) wires were the frequently used for the antegrade approach and SION and Fielder XT series for the retrograde channel crossing (all from ASAHI, Nagoya, Japan). The guide wire details are given in [Fig. 1](#fig1){ref-type="fig"}. The mean stent length ± SD was 41.02 ± 19.61 mm. Of 339 lesions which were stented, 244 (72.1%) had single stent, 86 (25.4%) had two overlapping stents, and eight (2.5%) had three stents. The reasons for the procedural failure (*n* = 50) included failure to cross in 42 patients (84%), failure to track the balloon in two (4%), failure to dilate the balloon in three (6%), and no-reflow in three patients (6%). [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"} show successful retrograde techniques used for CTO PCI.Fig. 1Guide wires used for the CTO PCI. CTO, chronic total occlusion; PCI, percutaneous coronary intervention.Fig. 1Fig. 2Successful retrograde CTO PCI of the right coronary artery (RCA) by reverse CART technique. (**A)** Total occlusion of proximal RCA; (**B)** right anterior oblique view showing septal collateral channels and PDA connection; (**C)** antegrade vessel preparation with miracle 12 gm wire with a microcatheter (fine cross) support and retrograde microcatheter in the PDA; (**D)** retrograde wire changed to stiffer Gaia 2nd and antegrade--retrograde wire overlap established; (**E)** reverse CART with balloon inflation in the CTO segment (contemporary reverse CART); (**F)** retrograde wire advanced further proximal; (**G)** IVUS image showing retrograde wire confirmation at 3′o clock inside the plaque; (**H)** retrograde wire advanced further proximal to aorta; (**I)** antegrade wire at 12′oclock and IVUS catheter in the false lumen superiorly and to the right whereas retrograde wire in the lumen at 7′oclock, \* denotes false lumen and ˆ denotes true lumen; (**J)** wire positioning changed; (**K)** IVUS now shows both wires in the same lumen space; (**L)** donor vessel angiogram showing intact vessel; (**M)** RCA after stenting. CTO, chronic total occlusion; PCI, percutaneous coronary intervention; IVUS, intravascular ultrasound; CART, combined antegrade and retrograde technique; PDA, posterior descending artery.Fig. 2Fig. 3Successful retrograde CTO PCI of the left anterior descending coronary artery (LAD) by kissing wire technique. Patient had failed antegrade approach earlier due to ambiguous proximal CTO cap. (**A)** Angiogram showing chronic total occlusion of LAD; (**B)** retrograde CC1 channels filling LAD (vessel course marked); (**C)** right anterior oblique view showing channel tracking with Sion wire and Caravel micro catheter; (**D)** successful channel negotiation in to CTO segment; (**E)** wire exchange for Fielder XTR to penetrate the CTO body and wire kept as a marker; (**F)** antegrade wire advancement with Gaia 2nd in the direction of retrograde wire; (**G)** kissing wire technique with antegrade and retrograde wire overlap; (**H)** antegrade wire advancement and removal of the retrograde gear; (**I)** angiogram after 1.25 mm balloon dilatation showing diffusely calcified LAD; (**J)** rotational atherectomy with 15 mm burr; (**K)** LAD stenting with guide liner mother and child catheter assistance; (**L)** TIMI3 flow after stenting proximal LAD. CTO, chronic total occlusion; PCI, percutaneous coronary intervention; IVUS, intravascular ultrasound; TIMI, thrombolysis in myocardial infarction.Fig. 3

By univariate analysis ([Table 4](#tbl4){ref-type="table"}), the following factors were identified as predictors of procedural failure: previous MI (*p* = 0.023), occlusion length \> 10 mm (*p* = 0.037), occlusion length \> 20 mm (*p* = 0.003), presence of tortuosity (*p* \< 0.001), mild calcified lesions (*p* = 0.012), moderately calcified lesions (*p* = 0.025), severe calcified lesions (*p* = 0.001), presence of a side branch at the site of occlusion (*p* = 0.004), and blunt morphology of the occlusion (*p* \< 0.001). Unstable angina pectoris (*p* = 0.001) and tapered stump morphology (*p* = 0.001) were identified as a predictors of procedural success.Table 4Univariate analysis of predictors of procedural failure.Table 4VariableOdds ratio95% CI*p* valueMale1.3210.672--2.3400.577Age0.9870.973--1.0230.969Family history of CAD1.0860.733--1.9730.479Diabetes mellitus1.5660.826--2.6420.387Hypertension1.1210.616--2.0460.706Hypercholesterolemia1.3210.870--2.7280.237Smoking status Smoker1.3860.808--2.3400.340 Ex-Smoker0.6890.435--1.2180.326Previous MI0.5230.326--0.9250.033LVEF1.1090.978--1.0730.302Stable angina0.9870.574--1.5160.780Unstable angina3.3421.600--6.5590.001Previous CABG1.7650.574--2.8140.654Previous PCI Same artery1.0750.547--2.5620.668 Other artery1.0680.599--1.9060.823No. of diseased vessels 10.9800.577--1.5000.767 21.0560.642--1.7370.830 31.0360.562--1.9110.909Concomitant therapy Beta-blocker0.4910.137--1.7630.276ACE inhibitor and/or ARB1.0620.224--5.0240.140 Statin0.6560.138--3.1340.598 Nitrate0.6070.128--2.8800.530CTO RCA0.7740.481--1.2470.293 LAD1.3360.780--2.2980.391 LCx1.0330.592--1.8020.909Occlusion duration0.9980.992--1.0040.507CTO vessel diameter0.8560.488--1.5000.587J-CTO score parametersCTO length ≤10 mm1.5800.805--3.1000.183 10--20 mm1.8571.038--3.3210.037 ≥20 mm0.4740.228--0.7810.003Tortuosity0.3900.237--0.6400.001Calcification Mild0.5200.312--0.8650.012 Moderate0.2140.056--0.8250.025 Severe0.1250.035--0.4500.001Stump morphology Blunt0.1540.090--0.2630.001 Tapered6.0853.603--10.2780.001Side branch0.4980.301--0.7930.004In-stent CTO2.7500.766--9.8800.121CTO localization Ostial2.0260.783--5.2410.145 Proximal0.5100.509--1.3980.510 Medial0.9940.616--1.6050.980 Distal0.9140.471--1.7740.790Technical approach Anterograde0.3110.088--1.1010.070 Retrograde3.2120.908--11.3620.070Number of wires per lesion1.1140.844--1.4710.446Fluoroscopic time1.0110.998--1.0240.094Contrast volume1.0021.001--1.0040.009[^5]

Multivariate analysis of different angiographic components of J-CTO score showed tortuosity (*p* = 0.001), calcifications (*p ≤* 0.001), and blunt stump (*p* = 0.007), as independent predictors of procedural failure. With regards to clinical variables, a history of unstable angina pectoris was found to be a predictor of procedural success (*p* = 0.009).

3.1. Periprocedural complications ([Table 5](#tbl5){ref-type="table"}) {#sec3.1}
----------------------------------------------------------------------

There were three procedural deaths in the whole cohort. While performing left anterior descending artery (LAD)-CTO, one patient had left main thrombosis and cardiac arrest on table. One patient had severe hypotension and no reflow after stenting the right coronary artery (RCA). On IVUS examination, a large intramural hematoma was detected. There was no pericardial collection. Patient succumbed to cardiac arrest. The third patient had sudden death on the first postoperative day in the recovery ward. Coronary perforations were noted in nine (3.1%) patients, and large intramural hematoma with no reflow was documented in 12 (2.01%) patients. Cardiac tamponade occurred in two (1.4%) patients. Vascular complications included retroperitoneal hematoma1 (0.2%), femoral artery thrombosis in two (0.5%), and femoral artery pseudoaneurysm in four (1.02%) patients. Four patients had stent occlusions (1%) in the first year of follow-up.

3.2. Follow-up analysis {#sec3.2}
-----------------------

The median follow-up period was 63 months (interquartile range: 59--74). The total number of MACE was 48/389 (12.3%), and there were significantly higher adverse events in failure group (*p* \< 0.001) ([Table 6](#tbl6){ref-type="table"}). The MACE rate was significantly higher in the failure group (60%) than in success group (5.3%, *p* \< 0.001). The rate of TVR (both PCI and CABG) was statistically higher in the procedural failure group (*p* = 0.009). Non-adjusted analysis showed procedural success was found to be a significant predictor of MACE by univariable Cox regression analysis \[hazards ratio (HR): 0.423; 95% confidence interval (CI): 0.243--0.739; *p* = 0.002\]. Propensity score-adjusted Cox regression showed that procedural success remained a significant predictor of MACE (adjusted HR: 0.402; 95% CI: 0.196--0.824; *p* = 0.013). Kaplan--Meier curves showed significantly better survival without MACE in the group of patients with successful treatment of CTO. Average survival-free time from MACE in the procedural success group was 69 ± 2 months and 46 ± 3 months in the failure group (log rank: 15.247, *p* \< 0.001; HR: 2.7, 95% CI: 1.610--4.163, *p* \< 0.001). Although opening a CTO of a target vessel was associated with increased average MACE free time, there was no difference regarding a treated coronary artery \[log rank 2.098, *p* = 0.350; LAD compared with circumflex artery (LCx) (HR: 2.4, 95% CI: 0.690--0.8.060, *p* = 0.171); RCA compared with the LCx (HR: 0.796, 95% CI: 0.313--2.021, *p* = 0.631); and LAD compared with the RCA (HR: 1.4, 95% CI: 0.787--2.441, *p* = 0.259)\]. [Fig. 4](#fig4){ref-type="fig"} shows the Kaplan--Meier survival curves with respect to CTO PCI success or failure according to MACE-free survival. It was significantly better without MACE between CTO PCI success and CTO PCI failure in patients with CTO of the left LAD. In LAD patients, average survival free of MACE time in the procedural success group was 59.8 ± 2.4 months and 41.9 ± 6.8 months in the procedural failure group (log rank 14.638, *p* \< 0.001). There were no differences between CTO PCI success and CTO PCI failure in patients with CTO of the RCA (log rank 2.850, *p* = 0.091) or LCx (log rank 1.149, *p* = 0.284).Table 5Periprocedural complicationss.Table 5*n* (%)Total (389)SuccessFailure*p* valueDeath3210.9MI2 (0.7)1 0.6)1 (2)0.597Coronary perforation7 (1.7)4 (1.0)3 (6)0.068Cardiac tamponade3 (0.7)1 (0.5)2 (4)0.719Vascular complication7 (1.9)5 (1.4)2 (4)0.613Donor vessel dissection2 (0.5)1 (0.4)1 (2)0.719[^6]Table 6Major adverse cardiovascular events.Table 6MACE \[*n* (%)\]No of patients (*n* = 389)Procedure*p* valueSuccessful (*n* = 339)Failed (*n* = 50)CV Death5 (1.2)3 (0.8)2 (0.02)0.038MI2 (0.5)2 (0.5)0 (0)0.134TVR41 (10.5)13 (3.8)28 (36)0.009PCI24 (6.1)11 (3.2)13 (26)0.046CABG17 (3.9)2 (0.5)15 (30)0.05Total MACE48 (12.3)18 (5.3)30 (60)0.001[^7]Fig. 4Event-free survival rates following CTO PCI. CTO, chronic total occlusion; PCI, percutaneous coronary intervention.Fig. 4

3.3. Left ventricular function {#sec3.3}
------------------------------

Left ventricular function assessed in terms of EF in percentage (%) improved from 51.66 ± 12.1% at baseline to 54.6 ± 10.34% at 12 months clinical follow-up in patients (*n* = 339) who met procedural success (increase in the order of 4 ± 5 percentage points).

Whereas, it showed a declining trend from 51.12 ± 9.67% at baseline to 46.5 ± 10.1% at 12 months in patients (*n* = 50) who met procedural failure (decrease in the order of 4.3 ± 5 percentage points) as shown in [Fig. 5](#fig5){ref-type="fig"}.Fig. 5Left ventricular ejection fraction change after successful CTO PCI. CTO, chronic total occlusion; PCI, percutaneous coronary intervention; EF, ejection fraction.Fig. 5

4. Discussion {#sec4}
=============

This study attempts to look at the procedural and clinical outcomes of CTO PCI in a public hospital set up in a developing nation such as India. Patients with triple vessel disease and left main involvement were excluded. The overall success rate for the CTO was about 87%. This was slightly lower than published series from Japan and Western literature.[@bib5], [@bib23], [@bib24], [@bib25] We attribute this to the lesser usage of very complex techniques such as IVUS-guided true lumen puncture after sub-intimal entry (only 1% in this series). However, the results are comparable to the Indian series published recently.[@bib9] Interestingly, our retrograde numbers were also lesser (up to 10%) as against Japanese cohorts (up to 30%).[@bib5], [@bib25] We already have data showing improved success rates in complex CTO with hybrid/retrograde approaches.[@bib26], [@bib27] The mean J-CTO score was 1.7 marginally higher in failed cases (1.7 vs. 2) (*p* = 0.7), but when individual components of J-CTO score were compared against success and failure and tortuous and calcified CTOs, they showed higher failure rates in the multivariate analysis. CTO PCI improved symptoms, and a successful attempt reduced the MACE as shown in the previous studies.[@bib28], [@bib29], [@bib30] Developing economies such as India have logistic issues as well in accessibility for dedicated CTO tools for complex retrograde procedures which often have an impact on the outcomes.[@bib24], [@bib30]

The predominant CTO crossing technique was antegrade wire escalation (60%) followed by parallel wire technique (26%) in the antegrade approach, while reverse CART formed the major technique in the retrograde approach (5.6%). We believe the success rate can be even higher with more routine usage of retrograde techniques which could prove crucial in complex CTO success.[@bib5], [@bib24], [@bib25] The Japanese multicenter CTO registry showed higher success rates up to 95%.[@bib31].The registry has quoted up to 30% retrograde channel approach.[@bib32]

The periprocedural mortality was less than 1%, and the non-life threatening complications were about 4%. The clinical outcomes were acceptable and durable in this series. We had low MACE (5.3%) after a successful CTO PCI. The TLR rates were also acceptable in the relatively longer follow-up interval compared with previous studies from India by KsG et al and Goel et al.[@bib10], [@bib24] Although opening a CTO of a target vessel was associated with increased average MACE-free time, there was no difference regarding a treated coronary artery which was similar to previously published literature.[@bib5], [@bib9], [@bib33], [@bib34]

The important finding of the study was the positive impact of successful CTO PCI on left ventricular function. There was an improvement in the LVEF following successful CTO PCI at 6 months of follow-up contrary to the declining trend in the LVEF following failed CTO PCI. This improvement in LVEF was maintained at 24 months. This objective finding with statistical significance attests to the clinical outcome of CTO PCI as shown in earlier studies.[@bib32], [@bib34] We feel this is an important outcome, as it will stimulate CTO PCI programs in countries where facilities for such resource demanding procedures are not routinely met.

5. Limitations of the study {#sec5}
===========================

This study is mainly limited by the fact that it is a single-center non-randomized data. The number of patients was small enough to draw powerful long-term data. The study did not use any qualitative and quantitative intravascular ultrasound assessments, and therefore angiographic predictors of outcome cannot be discerned. Non-invasive stress testing test was not performed to objectively assess angina symptoms and performance. Absence of significant angina (CCS class III/IV; postprandial angina) at follow-up qualified to be considered as symptomatic benefit in our study besides taking into account the patients' symptom status at presentation. Myocardial viability assessment was not done in our study, but we have included only patients with symptom limiting daily activities, which indirectly corroborates for presence of viable myocardium downstream. The absence of a surgical arm of revascularization (CABG) is another limitation of this study.

6. Conclusions {#sec6}
==============

The success rates for CTO PCI in this registry was about 87%. Immediate and long-term clinical outcomes were better with lower MACE (5%) after a successful procedure. A key outcome variable included an increase in LVEF among patients after a successful CTO PCI. The overall periprocedural complications were about 5.5%, but majority were non-life threatening.
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[^1]: LVEF, left ventricular ejection fraction; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; DAPT, dual antiplatelet therapy; OR, odds ratio; CI, confidence interval; SD, standard deviation; MI, myocardial infraction; PCI, percutaneous coronary intervention; CAD, coronary artery disease; CABG, coronary artery bypass grafting.

[^2]: *p* ≤ 0.05.

[^3]: RCA, right coronary artery; CTO, chronic total occlusion; SD, standard deviation; LAD, left anterior descending artery; J-CTO, Japanese chronic total occlusion.

[^4]: IVUS, intravascular ultrasound; CART, controlled antegrade and retrograde tracking; CTO, chronic total occlusion.

[^5]: MI, myocardial infarction; LVEF, left ventricular ejection fraction; CABG, coronary artery bypass grafting; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; J-CTO, Japanese chronic total occlusion; LCx, circumflex artery; CAD, coronary artery disease; CI, confidence interval; LAD, left anterior descending coronary artery; RCA, right coronary artery; PCI, percutaneous coronary intervention.

[^6]: MI, myocardial infarction.

[^7]: MACE, major adverse cardiovascular events; CV death, cardiovascular death; MI, myocardial infarction; TVR, target vessel revascularization; PCI, percutaneous coronary intervention; CABG, coronary artery by-pass grafting.
